⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONC News
BeOne Medicines Ltd. American Depositary Shares
BeOne Medicines在ESMO 2026上公布針對難治性肝癌和肺癌的具說服力數據
businesswire.com
ONC
BeOne Medicines報告TEVIMBRA聯合ZIIHERA在一線HER2陽性胃食管癌中持續帶來生存獲益
businesswire.com
ONC
BeOne apresenta dados convincentes sobre tipos de câncer de fígado e pulmão de difícil tratamento na ESMO 2026
businesswire.com
ONC
BeOne präsentiert auf der ESMO 2026 überzeugende Daten zu schwer zu behandelndem Leber- und Lungenkrebs
businesswire.com
ONC
BeOne presenta dati convincenti nel trattamento dell'epatocarcinoma e del carcinoma polmonare difficile da trattare all'ESMO 2026
businesswire.com
ONC
BeOne presenteert interessante gegevens over moeilijk te behandelen lever- en longkanker tijdens ESMO 2026
businesswire.com
ONC
BeOne présente des données convaincantes sur les cancers du foie et du poumon difficiles à traiter lors du congrès de l’ESMO 2026
businesswire.com
ONC
BeOne presenta datos sólidos sobre cánceres de hígado y pulmón de difícil tratamiento en ESMO 2026
businesswire.com
ONC
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
businesswire.com
ONC
BeOne Medicines、HER2陽性胃食道がんの一次治療における「TEVIMBRA」と「ZIIHERA」の併用による生存期間延長効果の持続を報告
businesswire.com
ONC
JAZZ